Form 8-K - Current report:
SEC Accession No. 0001213900-20-007021
Filing Date
2020-03-20
Accepted
2020-03-20 17:24:44
Documents
6
Period of Report
2020-03-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea119842-8k_aytubio.htm 8-K 23876
2 FORM OF WARRANT ea119842ex4-1_aytubio.htm EX-4.1 82768
3 FORM OF PLACEMENT AGENTS WARRANTS ea119842ex4-2_aytubio.htm EX-4.2 87614
4 OPINION OF DORSEY & WHITNEY LLP ea119842ex5-1_aytubio.htm EX-5.1 16710
5 FORM OF SECURITIES PURCHASE AGREEMENT, DATED MARCH 12, 2020, BY AND BETWEEN THE ea119842ex10-1_aytubio.htm EX-10.1 201795
6 PRESS RELEASE DATED MARCH 12, 2020 ea119842ex99-1_aytubio.htm EX-99.1 14391
  Complete submission text file 0001213900-20-007021.txt   428478
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 20732951
SIC: 2834 Pharmaceutical Preparations